Celularity (CELU) Cost of Revenue (2020 - 2025)
Celularity (CELU) has disclosed Cost of Revenue for 6 consecutive years, with $7.4 million as the latest value for Q4 2025.
- For Q4 2025, Cost of Revenue changed 0.42% year-over-year to $7.4 million; the TTM value through Dec 2025 reached $20.1 million, up 33.92%, while the annual FY2025 figure was $20.1 million, 33.92% up from the prior year.
- Cost of Revenue hit $7.4 million in Q4 2025 for Celularity, up from $3.9 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $9.6 million in Q4 2023 and bottomed at $425000.0 in Q2 2022.
- Average Cost of Revenue over 5 years is $3.2 million, with a median of $2.7 million recorded in 2021.
- Year-over-year, Cost of Revenue soared 927.4% in 2021 and then decreased 25.57% in 2022.
- Celularity's Cost of Revenue stood at $2.8 million in 2021, then soared by 50.5% to $4.2 million in 2022, then surged by 129.83% to $9.6 million in 2023, then decreased by 23.58% to $7.3 million in 2024, then increased by 0.42% to $7.4 million in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods came in at $7.4 million, $3.9 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.